Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GI Trak is a private digital health company focused on gastrointestinal care rather than drug development. The company appears to operate the GiTrak platform and the Belly/Belly Health brand, which provide virtual GI nutrition and mental health support, symptom and diet tracking, medical-record organization, and provider-facing workflow tools. Its services are aimed at people living with chronic digestive conditions such as IBS, Crohn's disease, ulcerative colitis, celiac disease, GERD, and related disorders. Based on available public information, GI Trak functions as a healthcare technology-enabled services company with an active commercial offering, not a therapeutic biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GI Trak.